Study to Evaluate the Performance and Safety of ATF Implants and Lapé Médical Devices Implanted During Hip Arthroplasty
NCT ID: NCT05044767
Last Updated: 2023-02-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
4500 participants
OBSERVATIONAL
2021-06-07
2032-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Implant Survival in Patients With a Pinnacle Ultamet Device in Conventional Total Hip Joint Replacement
NCT01684631
Medium Term Survivorship of Cementless THA Performed Using the Bone Preservation Tri-Lock Femoral Stem
NCT01566916
Prospective and Obsevational Study of Total Hip Prothesis: HYPE Stem
NCT05560022
POLARSTEM Retrospective Multicenter Study
NCT02680340
Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip Arthroplasty
NCT05227924
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The post-market clinical follow-up study to be conducted by ATF Implants following this plan aims to collect data from the follow-up of patients before and after hip replacement surgery with implants manufactured by ATF Implants and Lapé médical. In current practice, the surgeon-investigator evaluates the patient pre- and post-operatively according to predefined criteria used in orthopedic surgery and more particularly in hp replacement surgery. Complications and adverse effects observed are also recorded.
The main objective is to gather clinical evidence to evaluate the survival rate of ATP Implants and Lapé médical hip prostheses over the long-term, namely 10 years.
The secondary objectives are to evaluate the performance and safety of the prostheses over the same period (i.e. 10 years), as well as to obtain feedback on the performance /intended use and safety of the surgical instruments required for implant placement.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
total hip arthroplasty
hip replacement surgery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
There are different indications for hip replacement surgery. The main ones are listed below:
* Dysplasia
* Primary Coxarthrosis
* Secondary Coxarthrosis
* Perthes disease
* Epiphysiolysis
* Ankylosing spondylitis
* Trochanteric bursitis
* Arthritis
* Degenerative arthritis
* Post-traumatic arthritis
* Rheumatoid arthritis
* Femoral neck fracture
* Osteonecrosis
* Revision
Depending on the specificities of the devices (size, absence/presence of a coating, material), indications may vary. This information can be found in the instruction for use. It is the surgeon's responsibility to select the most appropriate prosthesis for a given patient according to the patient's medical records and the instruction for use in force at the time of the procedure accompanying the medical device.
Exclusion Criteria
* An acute or chronic, local or systemic infection
* Severe muscular, neurological or vascular deficiency compromising the affected extremity
* A bone defect or insufficient bone quality that may compromise the stability of the implant
* Any concomitant disease (dysplastic coxarthrosis with extreme coxa valga, short neck and severe varus) that may affect the function of the implant
* Sensitivity to the material (allergy) Depending on the specificities of the devices (size, absence/presence of a coating, material), contraindications may vary. This information can be found in the instruction for use of the devices.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ATF Implants
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philippe Laffargue, Pr
Role: PRINCIPAL_INVESTIGATOR
Clinique du Croisé Laroche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Bordeaux - Hôpital Pellegrin
Bordeaux, , France
Clinique des Cèdres
Cornebarrieu, , France
Centre Ostéo-Articulaire des Cèdres
Échirolles, , France
Hôpital privé Drôme Ardèche
Guilherand-Granges, , France
Clinique du Croisé Laroche
Marcq-en-Barœul, , France
Polyclinique Saint George
Nice, , France
Groupe Hospitalier Diaconesses Croix Saint-Simon
Paris, , France
CHU de Poitiers
Poitiers, , France
Clinique de l'Atlantique
Puilboreau, , France
CHU St Etienne, Hôpital Nord
Saint-Etienne, , France
Polyclinique Sainte Thérèse
Sète, , France
Clinique de l'Orangerie
Strasbourg, , France
Hôpital privé du Vert Galant
Tremblay-en-France, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PEPS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.